Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
DWJ1464
DRUG
2 trials
Sponsors
Daewoong Pharmaceutical Co. LTD.
Conditions
Chronic Liver Disease
Healthy
Phase 1
Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers
NCT04477369
Daewoong Pharmaceutical Co. LTD.
Healthy
Start: 2020-08-06
End: 2020-09-30
Target: 28
Updated: 2020-07-29
Phase 4
Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease
Completed
NCT06272630
Daewoong Pharmaceutical Co. LTD.
Chronic Liver Disease
Start: 2023-02-06
End: 2024-03-29
Updated: 2024-12-30
Related Papers
Standard-Dose Ursodeoxycholic Acid Improves Biochemical Liver Function and Fibrosis in Chronic Liver Disease: Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
2026-05-18